Contributor Disclosures for Parapsoriasis

Role Name Disclosure Details Author  Henry K Wong, MD, PhD, Senior Professional Staff, Department of Dermatology, Henry Ford Hospital Nothing to disclose Details Medical Editor  Abby S Van Voorhees, MD, Assistant Professor, Director of Psoriasis Services and Phototherapy Units, Department of Dermatology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania Amgen Astellas Abbott Genentech Incyte Centocor Warner Chilcott Merck Details Pharmacy Editor  David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic 3M Pharmaceutical Graceway Pharmaceuticals Details Managing Editor  Christen M Mowad, MD, Assistant Professor, Department of Dermatology, Geisinger Medical Center Nothing to disclose Details CME Editor  Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania AMGEN AMGEN Genentech Centocor Centocor Covance Shire Details Chief Editor  William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System elsevier american college of physicians Details CONTRIBUTOR DISCLOSURE FORM Contributor Name: Henry K Wong  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Abby S Van Voorhees  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Amgen Honoraria Consulting   Astellas Grant/research funds Other   Abbott Honoraria Consulting   Genentech Honoraria Consulting   Incyte Grant/research funds Other   Centocor Honoraria Consulting   Warner Chilcott Honoraria Consulting   Merck Salary Review panel membership   Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: David F Butler  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** 3M Pharmaceutical Grant/research funds Other   Graceway Pharmaceuticals Grant/research funds Other   Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: Christen M Mowad, Managing Editor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Joel M Gelfand  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** AMGEN Consulting fee Consulting   AMGEN Grant/research funds None   Genentech Consulting fee Consulting   Centocor Consulting fee Consulting   Centocor Grant/research funds None   Covance Consulting fee Consulting   Shire Consulting fee Consulting   Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: William D James  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** elsevier Royalty Other   american college of physicians Honoraria Other   Off label or investigational use of medication